Projects

Bench to Clinic Roadmap

From The Global HIV Vaccine Enterprise Taking new vaccines into a phase I study requires comprehensive knowledge of a large number of issues in various areas and an understanding of how they impact one another, of which only a handful of investigators, funders and community representatives can fully fathom. Recognition of Read more…

By Roger, ago
Publications

Three key barriers to the effective translation of bioscience breakthroughs into patient benefit

In April 2012, speaking from Japan, a very symbolic location, the UK Minister for Universities and Science David Willetts announced the opening of a £180 million Biomedical Catalyst scheme to provide grant funding for innovative small and medium sized enterprises (SMEs) and academics to develop solutions to healthcare challenges. Prime Read more…

By Roger, ago
Selected writings

Wealth versus Health – the Thai Frontier

In the battle against HIV and AIDS, Thailand has been exemplary: since 2001, the AIDS death rate there has fallen by 79 percent, thanks to the supply of low-priced locally produced generic drugs and the 30-Baht universal health care scheme. But this success story is about to be challenged by the United States-Thai Free Trade Agreement (FTA) currently under negotiation, which includes restrictive intellectual property rights, and will put at risk the survival of hundreds of thousands of Thai people living with HIV, and beyond Thailand, the survival of millions who will be affected by the Thai precedent. (more…)

By Roger, ago